CLINICAL_TRIALS
trial_result
· 2014-11-06
Clinical Trial Update: A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma [Phase 3]
Summary
A Phase 3 study evaluated armodafinil for cancer-related fatigue in patients with multiple myeloma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oncotherapeutics | Conditions: Fatigue, Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2014-11-06